Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
September 20, 2022 05:18 ET | Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...
Wilmington Eye Welcomes New Fellowship-Trained Oculoplastic Surgeon
September 15, 2022 09:00 ET | Wilmington Eye
WILMINGTON, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Today, Wilmington Eye announced the addition of Dr. Molly Orban, a fellowship trained surgeon in ophthalmic plastic, reconstructive, and orbital...
Nacuity Pharmaceuticals and Arctic Therapeutics Enter Licensing Agreement and Strategic Partnership to Develop NPI-001
September 13, 2022 09:00 ET | Nacuity Pharmaceuticals, Inc.
FORT WORTH, Texas and REYKJAVIK, Iceland, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa,...
Global Cataract Surgery Devices Market to See 3.9% Annual Growth, Bolstered by Rising Geriatric Population
September 08, 2022 08:33 ET | Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Cataract Surgery Devices Market By Product, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added...
Global Advanced Ophthalmology Technologies Market Report 2022: Technological Advancements in Ophthalmic Devices Presents Avenues for Growth
September 06, 2022 04:58 ET | Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Advanced Ophthalmology Technologies Market (2022-2027) by Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with...
Iantrek logo and byline tight.jpg
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
August 30, 2022 08:00 ET | Iantrek, Inc.
WHITE PLAINS, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical device company founded by ophthalmic innovator Dr. Sean Ianchulev, announced the closing of a $23M Series B financing....
logo color s and clearside.jpg
Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022
August 25, 2022 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy
August 23, 2022 08:03 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
Straits Research Pvt Ltd
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
August 18, 2022 10:30 ET | Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
August 17, 2022 08:00 ET | Oyster Point Pharma, Inc.
PRINCETON, N.J., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), a commercial-stage biopharmaceutical company focused on the...